HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Zymergen (ZY) Investors of Securities Fraud Lawsuit, Advises Investors with Losses to Contact Firm’s Attorneys Now
SAN FRANCISCO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now .
- SAN FRANCISCO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now .
- 23, 2021 IPO concerning Hyaline, the Companys primary product that remains in the customer qualification stage.
- Were focused on investors losses and proving Zymergen lied about Hyalines business prospects, said Reed Kathrein, the Hagens Berman partner leading the investigation.
- Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.